Massachusetts Financial Services
PBYI icon

Massachusetts Financial Services’s Puma Biotechnology PBYI Stock Holding History

Massachusetts Financial Services’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-29,712
Closed -$3.47M – 893
2015
Q2 		$3.47M Sell
29,712
-395,867
-93% -$71.7M ﹤0.01% 706
2015
Q1 		$100M Buy
425,579
+11,723
+3% +$2.51M 0.05% 256
2014
Q4 		$78.3M Buy
413,856
+35,897
+9% +$7.96M 0.04% 274
2014
Q3 		$90.2M Buy
377,959
+42,294
+13% +$8.68M 0.05% 260
2014
Q2 		$22.2M Buy
+335,665
New +$23.9M 0.01% 514

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services's PBYI Position: Q3 2015 in Review

Massachusetts Financial Services sold out of Puma Biotechnology (PBYI) in Q3 2015, closing a stake of 29,712 shares — an estimated $3.47M sold.

Massachusetts Financial Services first reported a position in PBYI in Q2 2014 and held it in 5 quarters. The position peaked at $100M in Q1 2015. 163 funds tracked by Wall St. Rank hold PBYI as of Q3 2015.

  • Massachusetts Financial Services reported no remaining Puma Biotechnology position as of Q3 2015 after selling out during the quarter.
  • Massachusetts Financial Services sold 29,712 Puma Biotechnology shares in Q3 2015, an estimated $3.47M.
  • Massachusetts Financial Services first reported a position in Puma Biotechnology in Q2 2014 and held it in 5 quarters.
  • Massachusetts Financial Services's Puma Biotechnology position peaked at $100M in Q1 2015.
  • 163 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2015.

Based on Massachusetts Financial Services's 13F filing for Q3 2015, filed 12 Nov 2015.